Study with us
The Cancer Epidemiology Unit has an interdisciplinary team of academic researchers with expertise in epidemiology, statistics and clinical medicine. Many of the researchers supervise MSc and DPhil students and lecture on the MSc in Global Health Science and Epidemiology.
Students from the unit are encouraged to present their work at seminars in the unit, the department, and at national and international conferences.
The Nuffield Department of Population Health hosts weekly seminars, including the prestigious Richard Doll seminar series, covering a range of topics.
Our researchers are academic supervisors for students on the MSc in Global Health Science and Epidemiology, run by the Nuffield Department of Population Health. See the Study with Us section of the NDPH website for details of how to apply for this course.
We offer MSc students from Oxford and elsewhere summer research placements working on our large datasets. Please contact our research staff with your CV, details of your research background and research interests if you are interested in a short placement.
Our researchers are academic supervisors for some doctoral students in the Nuffield Department of Population Health.
Applications for entry to the DPhil in Population Health in October 2020 are now open.
CRUK DPhil Scholarships are available for these DPhil projects:
- Adiposity and other metabolic factors in relation to oesophageal cancer in diverse populations
- Breast density and other mammographic features in relation to breast cancer risk
- Diabetes and the risk of cancer in diverse populations
- Diet and risk of site-specific cancers in the Million Women Study: prospective research including 800,000 women
- Predictive and prognostic factors in early breast cancer and long term side effects of therapy
- Proteomics and prostate cancer: Assessing the role of inflammation in the development of aggressive prostate cancer
- The molecular epidemiology of prostate cancer: Assessing the association between genome-wide DNA methylation and risk for aggressive prostate cancer